Two deaths associated with measles were excluded from the measles dashboard of the Centers for Disease Control and Prevention, raising renewed concerns about the leadership and independence of new CDC ...
The House voted 370-48 Tuesday (Sept. 1) to pass a continuing resolution that funds the government through December without major changes from the Senate’s version, including provisions delaying a ...
Employees at HHS and most other federal workers would not get a raise next year for the second year in a row, under the pay adjustment plan President Donald Trump sent to Congress last week, angering ...
The Trump administration's revamp of the 1115 waiver budget neutrality process will likely affect the 15 states with demonstrations set to expire in 2026, according to a Manatt analysis released this ...
Democrats on the Senate Finance Committee are interested in establishing a subscription model to boost access to medicines like GLP-1s, one of many affordability policies lawmakers are considering ...
A key lawsuit between FDA and the states of Florida and Texas, which are attempting to compel FDA to revoke its 2000 approval of mifepristone, which would eliminate access to medication abortion ...
Companies developing agentic AI models for use in health care are pushing for a system of national licensure to avoid participation in the Interstate Medical Licensing Compact (IMLC), and at least one ...
HHS Secretary Robert F. Kennedy Jr. is escalating what’s increasingly becoming widespread scrutiny of the American Medical Association’s (AMA) control over the nation’s medical billing codes, accusing ...
The Trump administration’s most favored nation policy impacts about 89% of the brand drug market now that nine mid-sized manufacturers have signed up to offer their products to Medicaid at prices ...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
The health insurance industry is highlighting a new Health Affairs analysis that finds the No Surprises Act’s independent dispute resolution process resulted in $22.4 billion in costs from 2022 to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results